Insider Trades145 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 10,000 | $27.58 | $4.0B | -12.84% | +267.40% | $275.8K | +0.00% | 10b5-1 | Buy Now |
| Jul 17, 2026 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 7,090 | $45.05 | $4.0B | -12.84% | +267.40% | $319.4K | -1.28% | 10b5-1 | Buy Now |
| Jun 17, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 10,000 | $23.14 | $4.0B | -12.84% | +267.40% | $231.4K | +0.00% | 10b5-1 | Buy Now |
| Jun 17, 2026 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 12,036 | $23.14 | $4.0B | -12.84% | +267.40% | $278.5K | +0.00% | 10b5-1 | Buy Now |
| May 18, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 10,000 | $21.14 | $4.0B | -12.84% | +267.40% | $211.4K | +0.00% | 10b5-1 | Buy Now |
| Apr 17, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 10,000 | $25.08 | $4.0B | -12.84% | +267.40% | $250.8K | +0.00% | 10b5-1 | Buy Now |
| Mar 25, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 80,000 | $18.79 | $4.0B | -12.84% | +267.40% | $1.5M | +0.00% | 10b5-1 | Buy Now |
| Mar 17, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 10,000 | $15.12 | $4.0B | -12.84% | +267.40% | $151.2K | +0.00% | 10b5-1 | Buy Now |
| Mar 9, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 80,000 | $16.27 | $4.0B | -12.84% | +267.40% | $1.3M | +0.00% | 10b5-1 | Buy Now |
| Mar 6, 2026 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 10,000 | $29.58 | $4.0B | -12.84% | +267.40% | $295.8K | -16.39% | — | Buy Now |
| Feb 17, 2026 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 90,000 | $14.33 | $4.0B | -12.84% | +267.40% | $1.3M | +0.00% | 10b5-1 | Buy Now |
| Feb 6, 2026 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 5,000 | $29.04 | $4.0B | -12.84% | +267.40% | $145.2K | -0.67% | 10b5-1 | Buy Now |
| Jan 20, 2026 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 20,000 | $26.75 | $4.0B | -12.84% | +267.40% | $535.1K | -1.31% | 10b5-1 | Buy Now |
| Jan 9, 2026 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 48,300 | $27.99 | $4.0B | -12.84% | +267.40% | $1.4M | -10.09% | 10b5-1 | Buy Now |
| Jan 8, 2026 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 132,500 | $26.23 | $4.0B | -12.84% | +267.40% | $3.5M | -3.83% | 10b5-1 | Buy Now |
| Dec 22, 2025 | Buy | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 13,000 | $2.48 | $4.0B | -12.84% | +267.40% | $32.2K | +11.30% | — | Buy Now |
| Dec 19, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 5,000 | $16.84 | $4.0B | -12.84% | +267.40% | $84.2K | -0.55% | 10b5-1 | Buy Now |
| Dec 8, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,663 | $21.02 | $4.0B | -12.84% | +267.40% | $140.1K | -1.25% | 10b5-1 | Buy Now |
| Nov 19, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,500 | $22.33 | $4.0B | -12.84% | +267.40% | $279.2K | -0.69% | 10b5-1 | Buy Now |
| Nov 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,500 | $21.82 | $4.0B | -12.84% | +267.40% | $272.7K | -1.38% | 10b5-1 | Buy Now |
| Nov 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $17.40 | $4.0B | -12.84% | +267.40% | $116.0K | -1.22% | 10b5-1 | Buy Now |
| Oct 20, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,500 | $22.08 | $4.0B | -12.84% | +267.40% | $276.0K | -1.35% | 10b5-1 | Buy Now |
| Oct 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,500 | $21.33 | $4.0B | -12.84% | +267.40% | $266.7K | -1.37% | 10b5-1 | Buy Now |
| Oct 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $20.10 | $4.0B | -12.84% | +267.40% | $134.0K | -2.35% | 10b5-1 | Buy Now |
| Sep 29, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $11.44 | $4.0B | -12.84% | +267.40% | $74.4K | +0.00% | 10b5-1 | Buy Now |
| Sep 26, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 3,700 | $20.06 | $4.0B | -12.84% | +267.40% | $74.2K | -0.40% | 10b5-1 | Buy Now |
| Sep 26, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 4,000 | $20.25 | $4.0B | -12.84% | +267.40% | $81.0K | -0.43% | 10b5-1 | Buy Now |
| Sep 23, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 1,500 | $20.03 | $4.0B | -12.84% | +267.40% | $30.0K | -0.16% | 10b5-1 | Buy Now |
| Sep 23, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 2,800 | $20.03 | $4.0B | -12.84% | +267.40% | $56.1K | -0.30% | 10b5-1 | Buy Now |
| Sep 19, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 7,000 | $19.39 | $4.0B | -12.84% | +267.40% | $135.7K | -0.37% | 10b5-1 | Buy Now |
| Sep 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 6,000 | $19.29 | $4.0B | -12.84% | +267.40% | $115.7K | -0.32% | 10b5-1 | Buy Now |
| Sep 8, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $20.24 | $4.0B | -12.84% | +267.40% | $135.0K | -2.30% | 10b5-1 | Buy Now |
| Aug 27, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $11.55 | $4.0B | -12.84% | +267.40% | $75.1K | +0.00% | 10b5-1 | Buy Now |
| Aug 20, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 1,517 | $20.00 | $4.0B | -12.84% | +267.40% | $30.3K | -0.16% | 10b5-1 | Buy Now |
| Aug 19, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,500 | $19.86 | $4.0B | -12.84% | +267.40% | $248.2K | -0.66% | 10b5-1 | Buy Now |
| Aug 18, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 10,983 | $20.02 | $4.0B | -12.84% | +267.40% | $219.9K | -0.59% | 10b5-1 | Buy Now |
| Aug 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $18.24 | $4.0B | -12.84% | +267.40% | $121.6K | -1.14% | 10b5-1 | Buy Now |
| Jul 28, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $11.47 | $4.0B | -12.84% | +267.40% | $74.6K | +0.00% | 10b5-1 | Buy Now |
| Jul 21, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,500 | $22.29 | $4.0B | -12.84% | +267.40% | $278.6K | -0.65% | 10b5-1 | Buy Now |
| Jul 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,500 | $22.52 | $4.0B | -12.84% | +267.40% | $281.5K | -0.44% | 10b5-1 | Buy Now |
| Jul 10, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 2,000 | $12.57 | $4.0B | -12.84% | +267.40% | $25.1K | +0.00% | 10b5-1 | Buy Now |
| Jul 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $19.79 | $4.0B | -12.84% | +267.40% | $132.0K | -1.11% | 10b5-1 | Buy Now |
| Jun 27, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $11.69 | $4.0B | -12.84% | +267.40% | $76.0K | +0.00% | 10b5-1 | Buy Now |
| Jun 20, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,500 | $21.40 | $4.0B | -12.84% | +267.40% | $267.5K | -1.28% | 10b5-1 | Buy Now |
| Jun 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,500 | $22.18 | $4.0B | -12.84% | +267.40% | $277.3K | -0.65% | 10b5-1 | Buy Now |
| Jun 13, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,000 | $12.52 | $4.0B | -12.84% | +267.40% | $75.1K | +0.00% | 10b5-1 | Buy Now |
| Jun 9, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $20.34 | $4.0B | -12.84% | +267.40% | $135.6K | -1.09% | 10b5-1 | Buy Now |
| Jun 3, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 7,500 | $20.03 | $4.0B | -12.84% | +267.40% | $150.2K | -0.76% | 10b5-1 | Buy Now |
| Jun 3, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 7,500 | $20.05 | $4.0B | -12.84% | +267.40% | $150.4K | -0.77% | 10b5-1 | Buy Now |
| May 27, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $9.33 | $4.0B | -12.84% | +267.40% | $60.7K | +0.00% | 10b5-1 | Buy Now |
| May 19, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 5,000 | $16.31 | $4.0B | -12.84% | +267.40% | $81.5K | -0.50% | 10b5-1 | Buy Now |
| May 19, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 5,000 | $16.49 | $4.0B | -12.84% | +267.40% | $82.5K | -0.51% | 10b5-1 | Buy Now |
| May 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $18.39 | $4.0B | -12.84% | +267.40% | $122.6K | -0.71% | 10b5-1 | Buy Now |
| May 1, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 7,500 | $20.05 | $4.0B | -12.84% | +267.40% | $150.4K | -0.38% | 10b5-1 | Buy Now |
| May 1, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 7,500 | $20.06 | $4.0B | -12.84% | +267.40% | $150.4K | -0.38% | 10b5-1 | Buy Now |
| Apr 28, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $10.58 | $4.0B | -12.84% | +267.40% | $68.8K | +0.00% | 10b5-1 | Buy Now |
| Apr 21, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 5,000 | $16.07 | $4.0B | -12.84% | +267.40% | $80.4K | -0.25% | 10b5-1 | Buy Now |
| Apr 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 5,000 | $16.42 | $4.0B | -12.84% | +267.40% | $82.1K | -0.50% | 10b5-1 | Buy Now |
| Apr 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $18.04 | $4.0B | -12.84% | +267.40% | $120.3K | -0.69% | 10b5-1 | Buy Now |
| Mar 27, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $11.90 | $4.0B | -12.84% | +267.40% | $77.4K | +0.00% | 10b5-1 | Buy Now |
| Mar 24, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 2,000 | $12.49 | $4.0B | -12.84% | +267.40% | $25.0K | +0.00% | 10b5-1 | Buy Now |
| Mar 19, 2025 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,500 | $20.61 | $4.0B | -12.84% | +267.40% | $257.6K | -1.23% | 10b5-1 | Buy Now |
| Mar 17, 2025 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,500 | $20.83 | $4.0B | -12.84% | +267.40% | $260.3K | -1.25% | 10b5-1 | Buy Now |
| Mar 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $21.44 | $4.0B | -12.84% | +267.40% | $142.9K | -2.02% | 10b5-1 | Buy Now |
| Mar 4, 2025 | Buy | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 10,000 | $2.48 | $4.0B | -12.84% | +267.40% | $24.8K | +6.86% | — | Buy Now |
| Feb 27, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $11.44 | $4.0B | -12.84% | +267.40% | $74.4K | +0.00% | 10b5-1 | Buy Now |
| Feb 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 6,667 | $21.93 | $4.0B | -12.84% | +267.40% | $146.2K | -1.31% | 10b5-1 | Buy Now |
| Feb 5, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 2,000 | $12.50 | $4.0B | -12.84% | +267.40% | $25.0K | +0.00% | 10b5-1 | Buy Now |
| Jan 27, 2025 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $12.04 | $4.0B | -12.84% | +267.40% | $78.2K | +0.00% | 10b5-1 | Buy Now |
| Jan 7, 2025 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 50,067 | $14.48 | $4.0B | -12.84% | +267.40% | $725.1K | -0.86% | 10b5-1 | Buy Now |
| Dec 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 8,500 | $12.35 | $4.0B | -12.84% | +267.40% | $105.0K | +0.00% | 10b5-1 | Buy Now |
| Dec 13, 2024 | Buy | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 15,000 | $3.98 | $4.0B | -12.84% | +267.40% | $59.8K | +3.91% | 10b5-1 | Buy Now |
| Nov 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 10,500 | $13.69 | $4.0B | -12.84% | +267.40% | $143.7K | +0.00% | 10b5-1 | Buy Now |
| Oct 28, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 12,500 | $15.52 | $4.0B | -12.84% | +267.40% | $194.0K | +0.00% | 10b5-1 | Buy Now |
| Oct 18, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 716 | $30.00 | $4.0B | -12.84% | +267.40% | $21.5K | -0.21% | 10b5-1 | Buy Now |
| Oct 18, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 847 | $30.00 | $4.0B | -12.84% | +267.40% | $25.4K | -0.08% | 10b5-1 | Buy Now |
| Oct 18, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 1,628 | $16.24 | $4.0B | -12.84% | +267.40% | $26.4K | +0.00% | 10b5-1 | Buy Now |
| Oct 18, 2024 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 1,632 | $16.24 | $4.0B | -12.84% | +267.40% | $26.5K | +0.00% | 10b5-1 | Buy Now |
| Oct 18, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 924 | $30.00 | $4.0B | -12.84% | +267.40% | $27.7K | -0.09% | 10b5-1 | Buy Now |
| Oct 8, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 29,977 | $28.07 | $4.0B | -12.84% | +267.40% | $841.3K | -0.73% | 10b5-1 | Buy Now |
| Oct 8, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 51,145 | $28.11 | $4.0B | -12.84% | +267.40% | $1.4M | -1.22% | 10b5-1 | Buy Now |
| Oct 4, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 10,229 | $27.54 | $4.0B | -12.84% | +267.40% | $281.7K | -0.48% | 10b5-1 | Buy Now |
| Oct 4, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 22,976 | $14.99 | $4.0B | -12.84% | +267.40% | $344.5K | +0.00% | 10b5-1 | Buy Now |
| Oct 4, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 14,936 | $27.51 | $4.0B | -12.84% | +267.40% | $410.9K | -0.72% | 10b5-1 | Buy Now |
| Oct 1, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 526 | $27.54 | $4.0B | -12.84% | +267.40% | $14.5K | -0.05% | 10b5-1 | Buy Now |
| Oct 1, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 527 | $27.54 | $4.0B | -12.84% | +267.40% | $14.5K | -0.05% | 10b5-1 | Buy Now |
| Oct 1, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 1,042 | $15.01 | $4.0B | -12.84% | +267.40% | $15.6K | +0.00% | 10b5-1 | Buy Now |
| Sep 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 12,500 | $13.55 | $4.0B | -12.84% | +267.40% | $169.3K | +0.00% | 10b5-1 | Buy Now |
| Aug 29, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,000 | $22.49 | $4.0B | -12.84% | +267.40% | $269.8K | -0.55% | 10b5-1 | Buy Now |
| Aug 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 8,500 | $12.51 | $4.0B | -12.84% | +267.40% | $106.3K | +0.00% | 10b5-1 | Buy Now |
| Aug 26, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,000 | $22.89 | $4.0B | -12.84% | +267.40% | $274.7K | -1.13% | 10b5-1 | Buy Now |
| Jul 31, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 1,982 | $15.00 | $4.0B | -12.84% | +267.40% | $29.7K | +0.00% | 10b5-1 | Buy Now |
| Jul 31, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 2,270 | $27.56 | $4.0B | -12.84% | +267.40% | $62.6K | -0.21% | 10b5-1 | Buy Now |
| Jul 31, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 3,099 | $27.56 | $4.0B | -12.84% | +267.40% | $85.4K | -0.28% | 10b5-1 | Buy Now |
| Jul 29, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 10,500 | $14.58 | $4.0B | -12.84% | +267.40% | $153.1K | +0.00% | 10b5-1 | Buy Now |
| Jul 29, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,000 | $26.70 | $4.0B | -12.84% | +267.40% | $320.4K | -0.55% | 10b5-1 | Buy Now |
| Jul 25, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,000 | $24.92 | $4.0B | -12.84% | +267.40% | $299.1K | -0.37% | 10b5-1 | Buy Now |
| Jul 12, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,000 | $13.77 | $4.0B | -12.84% | +267.40% | $82.6K | +0.00% | 10b5-1 | Buy Now |
| Jul 12, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 50,000 | $25.06 | $4.0B | -12.84% | +267.40% | $1.3M | -4.48% | 10b5-1 | Buy Now |
| Jul 1, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 12,000 | $22.89 | $4.0B | -12.84% | +267.40% | $274.7K | -1.07% | 10b5-1 | Buy Now |
| Jun 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 8,500 | $12.52 | $4.0B | -12.84% | +267.40% | $106.5K | +0.00% | 10b5-1 | Buy Now |
| Jun 25, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 12,000 | $21.66 | $4.0B | -12.84% | +267.40% | $259.9K | -0.55% | 10b5-1 | Buy Now |
| Jun 6, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 2,266 | $11.27 | $4.0B | -12.84% | +267.40% | $25.5K | +0.00% | 10b5-1 | Buy Now |
| May 29, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 24,000 | $11.43 | $4.0B | -12.84% | +267.40% | $274.2K | +0.00% | 10b5-1 | Buy Now |
| May 28, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 8,500 | $12.83 | $4.0B | -12.84% | +267.40% | $109.1K | +0.00% | 10b5-1 | Buy Now |
| May 28, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 24,000 | $12.15 | $4.0B | -12.84% | +267.40% | $291.7K | +0.00% | 10b5-1 | Buy Now |
| May 14, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 2,214 | $13.74 | $4.0B | -12.84% | +267.40% | $30.4K | +0.00% | 10b5-1 | Buy Now |
| May 9, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 520 | $13.77 | $4.0B | -12.84% | +267.40% | $7.2K | +0.00% | 10b5-1 | Buy Now |
| May 6, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 9,750 | $12.60 | $4.0B | -12.84% | +267.40% | $122.9K | +0.00% | 10b5-1 | Buy Now |
| May 3, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 2,000 | $12.49 | $4.0B | -12.84% | +267.40% | $25.0K | +0.00% | 10b5-1 | Buy Now |
| Apr 29, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $9.73 | $4.0B | -12.84% | +267.40% | $63.2K | +0.00% | 10b5-1 | Buy Now |
| Apr 29, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 24,000 | $9.52 | $4.0B | -12.84% | +267.40% | $228.4K | +0.00% | 10b5-1 | Buy Now |
| Apr 25, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 24,000 | $9.01 | $4.0B | -12.84% | +267.40% | $216.1K | +0.00% | 10b5-1 | Buy Now |
| Apr 11, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 28,000 | $13.60 | $4.0B | -12.84% | +267.40% | $380.9K | +0.00% | 10b5-1 | Buy Now |
| Apr 11, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 32,403 | $14.66 | $4.0B | -12.84% | +267.40% | $475.1K | -3.21% | 10b5-1 | Buy Now |
| Apr 11, 2024 | Sell | ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | 40,000 | $13.78 | $4.0B | -12.84% | +267.40% | $551.1K | +0.00% | 10b5-1 | Buy Now |
| Apr 11, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 60,000 | $13.08 | $4.0B | -12.84% | +267.40% | $784.9K | +0.00% | 10b5-1 | Buy Now |
| Apr 11, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 95,418 | $13.08 | $4.0B | -12.84% | +267.40% | $1.2M | +0.00% | 10b5-1 | Buy Now |
| Apr 8, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 4,875 | $18.60 | $4.0B | -12.84% | +267.40% | $90.7K | -45.93% | 10b5-1 | Buy Now |
| Apr 1, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 24,000 | $9.86 | $4.0B | -12.84% | +267.40% | $236.6K | +0.00% | 10b5-1 | Buy Now |
| Mar 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $10.36 | $4.0B | -12.84% | +267.40% | $67.4K | +0.00% | 10b5-1 | Buy Now |
| Mar 25, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 24,000 | $9.34 | $4.0B | -12.84% | +267.40% | $224.1K | +0.00% | 10b5-1 | Buy Now |
| Mar 6, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 4,875 | $15.64 | $4.0B | -12.84% | +267.40% | $76.2K | -39.48% | 10b5-1 | Buy Now |
| Feb 29, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 24,000 | $8.77 | $4.0B | -12.84% | +267.40% | $210.4K | +0.00% | 10b5-1 | Buy Now |
| Feb 27, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $9.73 | $4.0B | -12.84% | +267.40% | $63.2K | +0.00% | 10b5-1 | Buy Now |
| Feb 26, 2024 | Sell | ELVN | Samuel Kintz | PRESIDENT AND CEO | 24,000 | $9.00 | $4.0B | -12.84% | +267.40% | $216.1K | +0.00% | 10b5-1 | Buy Now |
| Feb 6, 2024 | Sell | ELVN | Anish Patel | CHIEF OPERATING OFFICER | 4,875 | $15.11 | $4.0B | -12.84% | +267.40% | $73.7K | -28.31% | 10b5-1 | Buy Now |
| Jan 29, 2024 | Sell | ELVN | Benjamin Hohl | CHIEF FINANCIAL OFFICER | 6,500 | $9.15 | $4.0B | -12.84% | +267.40% | $59.4K | +0.00% | 10b5-1 | Buy Now |
| Jan 29, 2024 | Sell | ELVN | Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | 24,000 | $8.49 | $4.0B | -12.84% | +267.40% | $203.7K | +0.00% | 10b5-1 | Buy Now |
| Jan 25, 2024 | Sell | ELVN | Samuel Kintz | President and CEO | 24,000 | $8.40 | $4.0B | -12.84% | +267.40% | $201.7K | +0.00% | 10b5-1 | Buy Now |
| Jan 22, 2024 | Sell | ELVN | Anish Patel | Chief Operating Officer | 4,875 | $15.13 | $4.0B | -12.84% | +267.40% | $73.8K | -22.06% | 10b5-1 | Buy Now |
| Dec 29, 2023 | Sell | ELVN | Joseph P Lyssikatos | Chief Scientific Officer | 24,000 | $7.70 | $4.0B | -12.84% | +267.40% | $184.8K | +0.00% | 10b5-1 | Buy Now |
| Dec 28, 2023 | Sell | ELVN | Anish Patel | Chief Operating Officer | 13,540 | $15.02 | $4.0B | -12.84% | +267.40% | $203.3K | -13.29% | 10b5-1 | Buy Now |
| Dec 28, 2023 | Sell | ELVN | Benjamin Hohl | Chief Financial Officer | 23,740 | $8.75 | $4.0B | -12.84% | +267.40% | $207.8K | +0.00% | 10b5-1 | Buy Now |
| Dec 26, 2023 | Sell | ELVN | Samuel Kintz | President and CEO | 24,000 | $7.88 | $4.0B | -12.84% | +267.40% | $189.1K | +0.00% | 10b5-1 | Buy Now |
| Dec 22, 2023 | Sell | ELVN | Anish Patel | Chief Operating Officer | 1,085 | $15.03 | $4.0B | -12.84% | +267.40% | $16.3K | -1.50% | 10b5-1 | Buy Now |
| Dec 22, 2023 | Sell | ELVN | Benjamin Hohl | Chief Financial Officer | 2,260 | $8.77 | $4.0B | -12.84% | +267.40% | $19.8K | +0.00% | 10b5-1 | Buy Now |
| Dec 21, 2023 | Sell | ELVN | Joseph P Lyssikatos | Chief Scientific Officer | 13,132 | $7.09 | $4.0B | -12.84% | +267.40% | $93.1K | +0.00% | 10b5-1 | Buy Now |
| Dec 21, 2023 | Sell | ELVN | Samuel Kintz | President and CEO | 16,390 | $7.08 | $4.0B | -12.84% | +267.40% | $116.1K | +0.00% | 10b5-1 | Buy Now |
| Dec 20, 2023 | Sell | ELVN | Samuel Kintz | President and CEO | 15,558 | $7.07 | $4.0B | -12.84% | +267.40% | $110.0K | +0.00% | 10b5-1 | Buy Now |
| Dec 19, 2023 | Sell | ELVN | Joseph P Lyssikatos | Chief Scientific Officer | 17,776 | $7.07 | $4.0B | -12.84% | +267.40% | $125.6K | +0.00% | 10b5-1 | Buy Now |
| Nov 3, 2023 | Sell | ELVN | Samuel Kintz | President and CEO | 16,052 | $7.10 | $4.0B | -12.84% | +267.40% | $114.0K | +0.00% | 10b5-1 | Buy Now |
| Nov 3, 2023 | Sell | ELVN | Joseph P Lyssikatos | Chief Scientific Officer | 17,092 | $7.10 | $4.0B | -12.84% | +267.40% | $121.3K | +0.00% | 10b5-1 | Buy Now |
| Sep 29, 2023 | Sell | ELVN | Joseph P Lyssikatos | Chief Scientific Officer | 24,000 | $7.37 | $4.0B | -12.84% | +267.40% | $176.9K | +0.00% | 10b5-1 | Buy Now |
| Sep 25, 2023 | Sell | ELVN | Samuel Kintz | President and CEO | 24,000 | $7.46 | $4.0B | -12.84% | +267.40% | $179.1K | +0.00% | 10b5-1 | Buy Now |